• Wed, June 11, 2025
  • Thu, June 12, 2025
  • Fri, June 13, 2025
  • Sat, June 14, 2025
  • Sun, June 15, 2025
  • Mon, June 16, 2025
  • Tue, June 17, 2025

Merck's RSV drug approval and a drug manufacturer winds down

And more biotech news brought to you by The Readout.
The article from STAT News dated June 10, 2025, discusses several key developments in the biotech industry. 23andMe is facing scrutiny over its data privacy practices following a data breach, prompting calls for stricter regulations. Merck and Recursion Pharmaceuticals have announced a collaboration to accelerate drug discovery using AI, aiming to bring new treatments to market more quickly. Avidity Biosciences reported positive results from a clinical trial for a new muscular dystrophy treatment, boosting its stock price. The CDC has issued new guidelines on managing respiratory viruses, emphasizing the importance of updated vaccines. Lastly, Insmed's experimental treatment for a rare lung disease showed promising results in a late-stage trial, potentially offering new hope for patients.

Read the Full STAT Article at:
https://www.statnews.com/2025/06/10/biotech-news-23andme-data-privacy-merck-recursion-avidity-cdc-insmed-the-readout/

Like: 👍